Venky's (India) Limited (VENKEYS) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹20.1B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price −1.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹1,171 – ₹1,710 · fair‑value band ₹1,276 – ₹2,162 · the ₹1,426 price screens below the ₹1,719 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Venky's (India) Limited (VENKEYS) currently trades at ₹1,426, while our model-based Fair Value estimate is ₹1,719 — implying the stock looks roughly 20.5% undervalued today. We read business quality at 59/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Venky's (India) Limited generated revenue of ₹37.3B at a net margin of 3.7%. Revenue grew 30.5% year over year. It earns a return on equity of 9.1%. Net debt stands at ₹756M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Venky's (India) Limited primarily engages in the production and sale of poultry products in India and internationally. It operates through three segments: Poultry and Poultry Products, Animal Health Products, and Oilseed. The Poultry and Poultry Products segment produces and sells day old broiler and layer chicks, pathogen free eggs, processed chicken products, grownup commercial broiler, poultry feed, and other miscellaneous poultry products. Its Animal Health Products segment produces and sells medicines and other health products for birds. The Oilseed segment produces and sells edible refined soya oil and soya de-oiled cake. It also provides nutritional supplements, toxin binders, liver tonics, acidifiers, health promoters, iron tonic, antibiotics, anti-mycoplasma, dewormers, anti-gout, and electrolytes; disinfectants, water sanitizers, cleaners, and equipment; vitamin premixes and prebiotics; sports and medical nutrition, therapy products; egg powders; vaccines; and feed …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Venky's (India) Limited reported revenue of ₹37.3B in FY2026 versus ₹44.0B in FY2022, a compound −4.1%/yr. Reported net income was ₹1.4B in FY2026, compounding −4.1%/yr from FY2022.
Is VENKEYS fairly valued? → Check now
Similar stocks
6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $76.29 | $46.97 | -38% |
| MHP SE MHPC | $0.0860 | $0.0100 | -88% |
| Muyuan Foods Group 002714 | ¥35.06 | ¥49.23 | +40% |
| Bunge Global SA BG | $128.21 | $88.65 | -31% |
| Tyson Foods, Inc TSN | $56.13 | $46.40 | -17% |
| Wens Foodstuff Group 300498 | ¥12.83 | ¥7.44 | -42% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Venky's (India) Limited (VENKEYS) undervalued?
What is the fair value of VENKEYS?
What is the quality score of VENKEYS?
What is the revenue of Venky's (India) Limited (VENKEYS)?
What is the net profit margin of VENKEYS?
Does Venky's (India) Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.